Companies Dominating the Neuroblastoma Drugs Landscape
- CELLECTAR BIOSCIENCES, INC.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- APEIRON Biologics AG
- Pfizer Inc.
- Eli Lilly and Company
- AstraZeneca
- Teva Pharmaceutical Industries Ltd.
- Bristol-Myers Squibb Company
- MacroGenics Inc.
- Marsala Biotech Inc.
- Johnson & Johnson Services, Inc.
Browse Key Market Insights with Data Illustration:
In the News
-
Teva Pharmaceutical Industries Ltd. in Association with Global HOPE (Hematology Oncology Pediatric Excellence) donated over 566,000 doses of medicine, and helped with the training of over 5,600 healthcare professionals across Africa by providing required care, health services, and medical resources.
-
Eli Lilly and Company started research on genomic testing in cancer in order to find weaknesses in tumor makeup and to design more targeted treatment. Further, Lilly Oncology is working to spread the knowledge about genomic testing in cancer diagnosis and treatment.
